首页> 外国专利> New organic compounds based on bis - biguanides and (-, guanidines and their preparation,

New organic compounds based on bis - biguanides and (-, guanidines and their preparation,

机译:基于双-双胍和(-,胍类的新型有机化合物及其制备方法,

摘要

The invention comprises compounds of the formula FORM:1095902/C2/1 in which R denotes an alkyl radical of 6-16 carbon atoms or a radical alkyl-Y-alkylene, in which Y is oxygen or sulphur and the alkyl and alkylene groups together contain 3-15 carbon atoms, R1 denotes hydrogen or an alkyl radical of 1-6 carbon atoms, x is 1 or 2 and A denotes any of the following bridging groups: (1) an alkylene group of 2-12 carbon atoms; (2) a group -(CH2)m-Y-(CH2)n-, in which m and n denote integers from 2 to 6; (3) a group FORM:1095902/C2/2 (4) a group FORM:1095902/C2/3 in which Z and Z1 are each alkylene of 1-3 carbon atoms; (5) a group FORM:1095902/C2/4 in which Q denotes -O-, -S-, -SO- or -SO2-; (6) a diphenyl residue; or (7) a stilbene residue. A number of groups which A and R may denote are specified. The compounds in which x is 2 (bisbiguanides) may be prepared (1) by reacting a bridged bis-(3-cyanoguanidine) of the formula NC-NH-C(:NH)-NH-A-NH-C(:NH)-NH-CN (or an amidino-O-alkylurea equivalent thereof) with an amine R(R1)NH in salt form; or (2) by reacting a diamine H2N-A-NH2, optionally in salt form, with a 1-alkyl-3-cyanoguanidine of the formula R-N(R1)-C(:NH)-NH-CN. The compounds in which x is 1 (bisguanidines) may be prepared by reacting an appropriate N-alkyl-S-alkylisothiuronium halide with an appropriate bridged diamine. The products form mono- and di-acid salts with inorganic or organic acids, including mono- or di-carboxylic, sulphonic, sulphinic, phosphonic and phosphinic acids, organic acids of arsenic or antimony, acidic phenolic compounds and Lewis acids. A number of suitable acids are specified. The products also form co-ordination complexes with various heavy-metal ions, e.g. those of vanadium, chromium, manganese, cobalt, nickel, copper, zinc, palladium, rhenium and osmium. In typical examples: (1) 1,1-hexamethylene-bis - (3 - cyanoguanidine) and n - hexylamine hydrochloride yield 1,11-hexamethylene-bis [5-hexylbiguanide], (2) p-phenylene diamine and 1 - n - octyl - 3 - cyanoguanidine yield 1,11-(p-phenylene) - bis - [5 - (n - octyl) biguanide; (3) N - hexyl - S - ethylisothiuronium iodide and hexamethylene diamine yield 1,11-hexamethylene - bis - (3 - hexylguanidine). Other specified products include a cobalt complex of 1,11-hexamethylene - bis - [5 - (2 - ethylhexyl) biguanide], 1,11 - hexamethylene - bis - [5-(2-ethoxyethyl) biguanide], 1,11-hexamethylene-bis - [5 - (3 - isopropylmercaptopropyl) biguanide], 1,11 - thiobis - (p - phenylene) bis - (5-octylbiguanide), 1,11 - sulphinyl bis - (p-phenylene) bis - (5 - octylbiguanide), 1,11-sulphonyl bis - (p - phenylene) bis - (5 - octylbiguanide), 1,11 - (4,41 - stilbene) bis - (5 - octylbiguanide), 1,11 - [1,4 - cyclohexane bis-(methylene)] bis - (3 - hexylguanidine), 1,11-(p,p1 - biphenylene) bis - (3 - hexylguanidine), 1,11 - (2,3,5,6 - tetrachloro - p - xylylene) bis-[5 - (2 - ethylhexyl) biguanide], and 1,11-hexamethylene - [3 - (5 - methylmercaptopentyl)-guanidine]. The products show antibacterial and fungicidal activity (see Division A5).ALSO:As disinfectants, fungicides and skin and hair conditioners, use is made of bisbiguanides and bisguanidines of the formula FORM:1095902/A5-A6/1 in which x is 1 or 2, R denotes an alkyl radical of 6-16 carbon atoms or a radical alkyl-Y-alkylene, in which Y is oxygen or sulphur and the alkyl and alkylene groups together contain 3-15 carbon atoms, R1 denotes hydrogen or an alkyl radical of 1-6 carbon atoms, and A denotes any of the following bridging groups:-(1) an alkylene group of 2-12 carbon atoms, (2) a group -(CH2)m-Y-(CH2)n-, in which m and n denote integers from 2 to 6, (3) a group FORM:1095902/A5-A6/2 (4) a group FORM:1095902/A5-A6/3 in which Z and Z1 are each alkylene of 1-3 carbon atoms, (5) a group FORM:1095902/A5-A6/4 in which Q denotes -O-, -S-, -SO- or -SO2, (6) a diphenyl residue or (7) a stilbene residue (see Division C2). The compounds may be used as such or as their mono- or di-addition salts with acids. Comparative experimental results are given of the use of some of the compounds as bactericides, bacteriostats, fungicides and fungistats, and example 4 describes the treatment of cotton cloth with one of the compounds to impart an anti-bacterial finish thereto. It is stated also that some of the products are active against influenza virus and that other products have antihelmintic activity.
机译:本发明包括式的化合物,其中R表示6至16个碳原子的烷基或烷基-Y-亚烷基,其中Y是氧或硫且烷基和亚烷基这些基团一起包含3-15个碳原子,R1表示氢或1-6个碳原子的烷基,x为1或2,A表示以下任何桥接基团:(1)2-12个碳原子的亚烷基; (2)基团-(CH 2)m -Y-(CH 2)n-,其中m和n表示2至6的整数。 (3)基团(4)基团,其中Z和Z1各自为1-3个碳原子的亚烷基。 (5)组,其中Q表示-O-,-S-,-SO-或-SO2-; (6)二苯基残基;或(7)二苯乙烯残基。指定了A和R可以表示的多个基团。 x为2的化合物(双双胍)可通过使式NC-NH-C(:NH)-NH-A-NH-C(:NH)的桥联双-(3-氰基胍)反应来制备(1) )-NH-CN(或其a基-O-烷基脲等效物)与盐形式的胺R(R1)NH; (2)使二胺H 2 N-A-NH 2(任选以盐的形式)与式R-N(R 1)-C(:NH)-NH-CN的1-烷基-3-氰基胍反应。 x为1的化合物(双胍)可以通过使合适的N-烷基-S-烷基异硫脲鎓卤化物与合适的桥联二胺反应来制备。产物与无机或有机酸形成一元和二元酸盐,包括一元或二元羧酸,磺酸,亚磺酸,膦酸和次膦酸,砷或锑的有机酸,酸性酚类化合物和路易斯酸。指定了许多合适的酸。产物还与各种重金属离子,例如重金属离子形成配位络合物。钒,铬,锰,钴,镍,铜,锌,钯,rh和的那些。在典型的例子中:(1)1,1-六亚甲基-双-(3-氰基胍)和正己胺盐酸盐的收率1,11-六亚甲基-双[5-己基双胍],(2)对苯二胺和1-n -辛基-3-氰基胍产量1,11-(对亚苯基)-双-[5-(正辛基)双胍; (3)N-己基-S-乙基异硫脲碘化物和六亚甲基二胺产生1,11-六亚甲基-双-(3-己基胍)。其他指定产品包括1,11-六亚甲基-双-[5-(2-乙基己基)双胍],1,11-六亚甲基-双-[5-(2-乙氧基乙基)双胍],1,11-六亚甲基双-[5-(3-异丙基巯基丙基)双胍],1,11-硫双-(对-亚苯基)双-(5-辛基双胍),1,11-亚磺酰基双-(对-亚苯基)双-(5 -辛基双胍),1,11-磺酰基双-(对亚苯基)双-(5-辛基双胍),1,11-(4,41-二苯乙烯)双-(5-辛基双胍),1,11-[1, 4--环己烷双((亚甲基)]双-(3-己基胍),1,11-(对,p1-联苯撑)双-(3-己基胍),1,11-(2,3,5,6-四氯-对-亚二甲苯基)双-[5-(2-乙基己基)双胍]和1,11-六亚甲基-[3-(5-甲基巯基戊基)-胍]。该产品显示出抗菌和杀真菌活性(参见A5部分).ALSO:作为消毒剂,杀菌剂以及皮肤和头发调理剂,使用式的双双胍和双胍,其中x为在图1或2中,R表示6-16个碳原子的烷基或烷基-Y-亚烷基,其中Y是氧或硫,并且烷基和亚烷基基团一起包含3-15个碳原子,R1表示氢或氢。 1-6个碳原子的烷基,且A表示以下任何桥接基团:-(1)2-12个碳原子的亚烷基,(2)-(CH2)mY-(CH2)n-基团,其中m和n表示2到6的整数,(3)组(4)组其中Z和Z1是每个具有1-3个碳原子的亚烷基,(5)基团,其中Q表示-O-,-S-,-SO-或-SO2,(6)二苯基残基或(7)二苯乙烯残基(请参阅C2部分)。该化合物可以原样使用或与酸的单或双加成盐使用。给出了使用某些化合物作为杀菌剂,抑菌剂,杀真菌剂和抑真菌剂的比较实验结果,实施例4描述了用一种化合物处理棉布以赋予其抗菌性。还指出某些产品对流感病毒具有活性,而其他产品则具有抗蠕虫活性。

著录项

  • 公开/公告号FR1463818A

    专利类型

  • 公开/公告日1966-07-22

    原文格式PDF

  • 申请/专利权人 STERLING DRUG INC;STERLING DRUG INC.;

    申请/专利号FR19650012484

  • 发明设计人

    申请日1965-04-08

  • 分类号A01N47/44;A61K8/43;A61K31/155;A61Q5;A61Q5/12;A61Q17;C07C279/26;C07C317/42;C07C323/44;

  • 国家 FR

  • 入库时间 2022-08-23 14:47:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号